Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Carlos Rodriguez-Escalera"'
Autor:
Laura Muñoz-Barrera, Carlos Perez-Sanchez, Rafaela Ortega-Castro, Sagrario Corrales, Maria Luque-Tevar, Tomás Cerdó, Ismael Sanchez-Pareja, Pilar Font, Raquel Lopez-Mejías, Jerusalem Calvo, M.Carmen Abalos-Aguilera, Desiree Ruiz-Vilchez, Pedro Segui, Christian Merlo, José Perez-Venegas, Ma Dolores Ruiz Montesino, Carlos Rodriguez- Escalera, Carmen Romero Barco, Antonio Fernandez-Nebro, Natalia Mena Vazque, Jose Luis Marenco, Julia Uceda Montañes, Javier Godoy-Navarrete, Alba Ma Cabezas-Lucena, Eduardo Collantes Estevez, Ma Angeles Aguirre, Miguel A. González-Gay, Nuria Barbarroja, Alejandro Escudero-Contreras, Chary Lopez-Pedrera
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 173, Iss , Pp 116357- (2024)
Background & objectives: This study aimed to: 1) analyze the inflammatory profile of Rheumatoid Arthritis (RA) patients, identifying clinical phenotypes associated with cardiovascular (CV) risk; 2) evaluate biologic and targeted-synthetic disease-mod
Externí odkaz:
https://doaj.org/article/085892cf1b36456385f1204967d195fa
Autor:
Maria Luque-Tévar, Carlos Perez-Sanchez, Alejandra Mª Patiño-Trives, Nuria Barbarroja, Ivan Arias de la Rosa, Mª Carmen Abalos-Aguilera, Juan Antonio Marin-Sanz, Desiree Ruiz-Vilchez, Rafaela Ortega-Castro, Pilar Font, Clementina Lopez-Medina, Montserrat Romero-Gomez, Carlos Rodriguez-Escalera, Jose Perez-Venegas, Mª Dolores Ruiz-Montesinos, Carmen Dominguez, Carmen Romero-Barco, Antonio Fernandez-Nebro, Natalia Mena-Vazquez, Jose Luis Marenco, Julia Uceda-Montañez, Mª Dolores Toledo-Coello, M. Angeles Aguirre, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Chary Lopez-Pedrera
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Background: This prospective multicenter study developed an integrative clinical and molecular longitudinal study in Rheumatoid Arthritis (RA) patients to explore changes in serologic parameters following anti-TNF therapy (TNF inhibitors, TNFi) and b
Externí odkaz:
https://doaj.org/article/bb017e91ba5d4f1ebf7fe17dc8217b1e
Autor:
Alejandra M. Patiño-Trives, Chary López-Pedrera, José Luis Marenco, Rafaela Ortega-Castro, Carlos Perez-Sanchez, M. Romero-Gómez, Iván Arias de la Rosa, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Natalia Mena-Vázquez, Nuria Barbarroja, Pilar Font, Antonio Fernández-Nebro, J.J. Pérez-Venegas, Desiree Ruiz-Vilchez, Carmen Dominguez, M. D. C. Abalos-Aguilera, C.M. Romero-Barco, Juan Antonio Marin-Sanz, M. Angeles Aguirre, Carlos Rodriguez-Escalera, Mª Dolores Ruiz-Montesinos, Julia Uceda-Montañez, María Luque-Tévar, Mª Dolores Toledo-Coello, Clementina López-Medina
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Frontiers in Immunology
Frontiers in Immunology
Background: This prospective multicenter study developed an integrative clinical and molecular longitudinal study in Rheumatoid Arthritis (RA) patients to explore changes in serologic parameters following anti-TNF therapy (TNF inhibitors, TNFi) and b
Publikováno v:
Cardiovascular Week; 4/1/2024, p637-637, 1p
Publikováno v:
Arthritis & Rheumatology; Oct2020 Supplement S10, Vol. 72, p1-4231, 4231p
Autor:
Pérez‐Sánchez, Carlos, Cecchi, Irene, Barbarroja, Nuria, Patiño‐Trives, Alejandra M., Luque‐Tévar, María, Pérez‐Sánchez, Laura, Ibáñez‐Costa, Alejandro, Arias de la Rosa, Iván, Ortega, Rafaela, Escudero, Alejandro, Castro, María Carmen, Radin, Massimo, Roccatello, Dario, Sciascia, Savino, Aguirre, María Ángeles, Collantes, Eduardo, López‐Pedrera, Chary
Publikováno v:
Journal of Cellular & Molecular Medicine; Sep2019, Vol. 23 Issue 9, p6308-6318, 11p
Autor:
Alejandro Ibáñez-Costa, C.M. Romero-Barco, Maria del Carmen Abalos-Aguilera, Nuria Barbarroja Puerto, Chary López-Pedrera, Carlos Rodríguez-Escalera, Natalia Mena-Vázquez, María Luque-Tévar, Dolores Ruiz-Montesinos, Iván Arias de la Rosa, Eduardo Collantes Estévez, Alejandro Escudero Contreras, Alejandra M. Patiño-Trives, Carlos Perez-Sanchez, M. Ángeles Aguirre-Zamorano, P. S. Laura, Julia Uceda, Mª Dolores Toledo-Coello, Rafaela Ortega Castro
Publikováno v:
Abstracts Accepted for Publication.
Objectives 1) To compare the real-world effectiveness among RA patients starting 3 biologic DMARDs (bDMARDs). 2) To evaluate whether patients’ clinical characteristics influence the response to specific bDMARDs. 3) To analyze the impact of bDMARDs